Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

False Claims

Advancing false-claims allegations that pharmaceutical companies paid kickbacks to providers that prescribe its anti-inflammatory drug, a federal judge found that one could conclude the government's "true motivation [in moving to dismiss] is animus toward the relator."

SPRINGFIELD, Ill. — Advancing false-claims allegations that pharmaceutical companies paid kickbacks to providers that prescribe its anti-inflammatory drug, a federal judge found that one could conclude the government's "true motivation [in moving to dismiss] is animus toward the relator."

Categories / Business, Government, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...